Patient surveillance after curative-intent surgery for rectal cancer

International Journal of Oncology

Volumn 27, Issue 3, 2005, Pages 815-822

  Johnson, Frank E ^a,b   Longo, Walter E ^c   Ode, Kenichi ^d   Shariff, Umar S ^e   Papettas, Trifonas ^e   McGarry, Alaine E ^a   Gammon, Steven R ^a   Lee, Paul A ^a   Audisio, Riccardo A ^d   Grossmann, Erik M ^a,b   Virgo, Katherine S ^a,b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c YALE UNIVERSITY   (United States)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Follow up; Outcomes; Postoperative; Rectal carcinoma; Surveillance

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL PRACTICE; HUMAN; METHODOLOGY; MIDDLE AGED; MONITORING; PATHOLOGY; POSTOPERATIVE CARE; QUESTIONNAIRE; RECTUM TUMOR; STATISTICS;

ADULT; AGED; HUMANS; MIDDLE AGED; MONITORING, PHYSIOLOGIC; NEOPLASM STAGING; PHYSICIAN'S PRACTICE PATTERNS; POSTOPERATIVE CARE; QUESTIONNAIRES; RECTAL NEOPLASMS;

EID: 24344479253     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Anonymous: The world health report 2002: reducing risks, promoting healthy life. Geneva: World Health Organization Press, 2002. Also see http://www.who.int/whr/2002/en/.
2. Ngeh JKT and Toh VKL: Letter to the editor. NEJM 348: 1407, 2003.
3. Jemal A, Murray T, Ward E, Samnels A, Tiwari RC, Ghafoor A, Feuer EJ and Thun MJ: Cancer statistics 2005. CA Cancer J Clin 55: 10-30, 2005.
4. Wingo PA, Cardinez CJ, Landis SH, Greenlee RT, Ries LA, Anderson RN and Thun MJ: Long-term trends in cancer mortality in the United States, 1930-1998. Cancer 97 (Suppl. 11): S3133-S3275, 2003.
5. Anonymous: Atlas of cancer mortality in the United States 1950-1994. National Institutes of Health. NIH Publication No. 99-4564: 124-133, 1999.
6. Cali RL, Pitsch RM, Thorson AG, Watson P, Tapia P, Blatchford GJ and Christensen MA: Cumulative incidence of metachronous colorectal cancer. Dis Colon Rectum 36: 388-393, 1993.
7. Green RJ, Metlay JP, Propert K, et al. Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of Intergroup 0089. Ann Int Med 136: 261-269, 2002.
8. Vijan S, Hwang EW, Hofer TP and Hayward RA: Which colon cancer screening test? A comparison of costs, effectiveness and compliances. Am J Med 111: 593-601, 2001.
9. Audisio RA, Kievit J, Wiggers T, Virgo KS and Johnson FE: Follow-up for colorectal cancer? Issue not settled. (May 9, 2002, letter in response to article in Brit Med J, April 6, 2002, by Rene an, et al. Impact on survival of intensive follow-up after curative resection for colorectal cancer: systematic review and meta-analysis of randomized trials). This letter is available in electronic form (email: raudisio@doctors.org.uk or internet: bmj.com) but not in printed form.
10. Johnson FE and Virgo KS (eds): Cancer patient follow-up. St. Louis, Mosby, 1997.
11. Renehan AG, O'Dwyer ST and Whynes DK: Cost effectiveness analysis of intensive versus conventional follow-up after curative resection for colorectal cancer. Brit Med J 328: 81-84, 2004.
12. Vernava AM, Longo WE, Virgo KS, Coplin MA, Wade TP and Johnson FE: Current follow-up strategies after resection of colon cancer. Results of a survey of The American Society of Colon and Rectal Surgeons. Dis Colon Rectum 37: 573-583, 1994
13. Virgo KS, Wade TP, Longo WE, Coplin MA, Vernava AM and Johnson FE: Surveillance after curative colon cancer resection: practice patterns of surgical subspecialists. Ann Surg Oncol 2: 472-482, 1995.
14. Virgo KS, Vernava AM, Longo WE, McKirgan LW and Johnson FE: Cost of patient follow-up after potentially curative colon cancer treatment. JAMA 273: 1837-1841, 1995.
15. Goldenberg DM, Neville AM, Carter AC, Go VLW, Holyoke ED, Isselbacher KJ, Schein PS and Schwartz M: Carcinoembryonic antigen: its role as a marker in the management of cancer: Summary of an NIH consensus statement. Br Med J 282: 373-375, 1981.
16. The American Society of Colon and Rectal Surgeons Standards Task Force: Practice parameters for the detection of colorectal neoplasms. Dis Colon Rectum: 389-394, 1994.
17. Anonymous: Colon and rectal cancer - treatment guidelines for patients. Version II/June 2002. Published by the American Cancer Society and National Comprehensive Cancer Network (www.cancer.organdwww.nccn.org).
18. McLeod PI, Tamblyn RM, Gayton D, Grad R, Snell L, Berkson L and Abrahamowicz M: Use of standardized patients to assess between-physician variations in resource utilization. JAMA 278: 1164-1168, 1997.
19. Fleisher DE, Goldberg SB, Browning TH, Cooper JN, Friedman E, Goldner FH, Keeffe EB and Smith LE: Detection and surveillance of colorectal cancer. JAMA 261: 580-585, 1989.
20. Earle CC, Grunfield E, Coyle D, Cripps MC and Stern HS: Cancer physicians' attitudes toward colorectal cancer follow-up. Ann Oncol 14: 400-405, 2003.
21. Moertel CG, Fleming TR, MacDonald JS, Haller DG, Laurie JA and Tangen C: An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 270: 943-947, 1993.
22. Kolata G: Questions grow over usefulness of some routine cancer tests. The New York Times, page 1, section A, December 30, 2001.
23. Bruinvels DJ, Stiggelbout AM, Kievit J, van Houwelingen HC, Habbema JD and van de Velde CJ: Follow-up of patients with colorectal cancer. A meta-analysis. Ann Surg 219: 174-182, 1994.
24. Rosenau PV: Managing medical technology: lessons for the United States from Quebec and France. Int J Health Serv 30: 617-639,2000.
25. Dozet A and Fisher L: Incentives for diffusion of new health care technology. Dev Health Econ Public Policy 7: 161-185, 1998.
26. Kosecoff J, Kancouse DE, Rogers WH, McCloskey L, Winslow CM and Brook RH: Effects of National Institutes of Health consensus development program on physician practice. JAMA 258: 2708-2713, 1987.
27. Johnson FE, Virgo KS and Fossati R: Follow-up for patients with colorectal cancer after curative-intent primary treatment. J Clin Oncol 22: 1363-1365, 2004.
28. Bloom FE: Presidential address to the American Association for the Advancement of Science. Science as a way of life: perplexities of a physician-scientist. Science 300: 1680-1685, 2003.
29. Field MJ and Lohr KN (eds): Guidelines for Clinical Practice. From Development to use. National Academy Press, Washington DC, p34, 1992.
30. Ault A: Climbing a medical Everest. Science 300: 2024-2025, 2003.
31. Krzyzanowska MK, Pintilie M and Tannock IF: Factors associated with failure to publish large randomized trials presented at an oncology meeting. JAMA 290: 495-501, 2003.
32. Phelps CE, Parente ST. Priority setting in medical technology and medical practice assessment. Med Care 28:703-723, 1990.
33. Razor J: Health care and competition law and policy: a yearlong dialogue. Bull Am Coll Surg 888: 8-11, 2003.
34. Cohen JW and Krauss NA: Spending and service use among people with the fifteen most costly medical conditions. Health Affairs 22: 129-138, 2003.
35. Anonymous: The Burden of Gastrointestinal Diseases. Bethesda, American Gastroenterological Association, 2001.
36. Kohn LT, Corrigan JM, Donaldson MS (eds): To Err is Human: Building a Safer Health Care System. National Academy Press, Washington, DC, 1999.
37. Wennberg J: Unwarranted variations in health care delivery: implications for academic medical centres. Brit Med J 325: 961-964,2003.
38. Chassin MR, Galvin RW and the National Roundtable on Health Care Quality: The urgent need to improve health care quality. JAMA 280: 1000-1005, 1998.
39. Steiner CA, Powe NR, Anderson GF and Das A: Technology coverage decisions by health care plans and considerations by medical directors. Medical Care 35: 472-489, 1997.
40. Hermann RC, Dorwart RA, Hoover CW and Brody J: Variation in ECT use in the United States. Am J Psychiatry 152: 869-875, 1995.
41. Powe NR, Steiner CA, Anderson GF and Das A: Awareness of providers' use of new medical technology among private health care plans in the United States. Int J Technol Assess Health Care 12: 367-376, 1996.
42. Weiner JP, Starfield BH, Powe NR, Stuart ME and Steinwachs DM: Ambulatory care practice variation within a Medicaid program. Health Serv Res 30: 751-770, 1995.
43. Allison JJ, Kiefe CI, Cook EF, Gerrity MS, Orav EJ and Centor R: The association of physician attitudes about uncertainty and risk taking with resource use in a Medicare HMO. Med Decis Making 18:320-329,1998.
44. The Physicians' Working Group for Single-Payer National Health Insurance: Proposal of the Physicians' Working Group for Single-Payer National Health Insurance. JAMA 290: 798-805 2003.
45. Landro L: Six prescriptions to ease rationing in U.S. health care. Wall Street Journal, December 22, p Al, 2003.
46. Mariotto A, Warren JL, Knopf KB and Feuer EJ: The prevalence of patients with colorectal carcinoma under care in the US. Cancer 98: 1253-1261,2003.
47. GIVIO Investigators: Impact of follow-up testing on survival and health-related quality of life in breast cancer patients: a multicenter randomized controlled trial. JAMA 271: 1587-1592, 1994.
48. Del Turco MR, Palli D, Cariddi S, Ciatto S, Pacini P and Distante V: Intensive diagnostic follow-up after treatment of primary breast cancer: a randomized trial. JAMA 271: 1593-1597, 1994.